“THE IMPACT OF THE EUROPEAN CLINICAL TRIALS REGULATION ON GLOBAL CLINICAL DEVELOPMENT”

Chair:

Ingrid Klingmann, MD, PhD, Chairman at EFGCP, President at PharmaTrain Federation, Managing Director at Pharmaplex

Speakers:

‘Will the EU Clinical Trial Regulation make Europe a more attractive region for global sponsors of clinical trials?’

Silvia Garcia, Clinical trials expert Science Policy and Regulatory Affairs, EFPIA

‘Will the new EU regulatory framework for trials in different vulnerable populations set the standard for more diversity?’

Derick Mitchell, CEO of IPPOSI, Ireland

‘Will the EU become the driver for transparency of clinical trial results?’

Anne-Sophie Henry-Eude, Head of Document Access and Publication Department, EMA 

 

Speakers